Corcept Therapeutics, Inc. (CORT)
51.04
-1.10
(-2.12%)
USD |
NASDAQ |
May 07, 16:00
51.60
+0.56
(+1.09%)
After-Hours: 20:00
Corcept Therapeutics Research and Development Expense (Annual) : 254.91M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 12.51B |
| Integer Holdings Corp. | 46.35M |
| Stryker Corp. | 1.567B |
| Supernus Pharmaceuticals, Inc. | 104.13M |
| Terns Pharmaceuticals, Inc. | 77.89M |